Sclerosis  >>  Lodonal (naltrexone low dose oral)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
NCT00501696: A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Completed
3
80
US
4.5 mg Naltrexone, Naltrexon(4.5mg) or placebo , crossover-design, Naltrexone, Naltrexone(4.5mg) or placebo , crossover-design
University of California, San Francisco
Multiple Sclerosis
11/07
11/07

Download Options